Encompass Health Corporation $EHC Shares Purchased by New York State Teachers Retirement System

New York State Teachers Retirement System increased its stake in shares of Encompass Health Corporation (NYSE:EHC) by 0.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,202 shares of the company’s stock after purchasing an additional 100 shares during the period. New York State Teachers Retirement System owned 0.08% of Encompass Health worth $9,345,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of EHC. Congress Asset Management Co. acquired a new position in Encompass Health in the 2nd quarter valued at $92,691,000. Nuveen LLC acquired a new position in Encompass Health in the 1st quarter valued at $50,665,000. T. Rowe Price Investment Management Inc. raised its holdings in Encompass Health by 25.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock valued at $210,756,000 after acquiring an additional 424,691 shares during the last quarter. Strs Ohio acquired a new position in Encompass Health in the 1st quarter valued at $34,364,000. Finally, American Century Companies Inc. raised its holdings in Encompass Health by 78.6% in the 1st quarter. American Century Companies Inc. now owns 723,169 shares of the company’s stock valued at $73,243,000 after acquiring an additional 318,251 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Trading Up 1.3%

EHC stock opened at $124.55 on Monday. The business has a fifty day simple moving average of $123.56 and a 200-day simple moving average of $117.36. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.86. The company has a market cap of $12.55 billion, a price-to-earnings ratio of 24.37, a PEG ratio of 2.18 and a beta of 0.93.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were given a dividend of $0.19 per share. This is a positive change from Encompass Health’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health’s dividend payout ratio is currently 14.87%.

Wall Street Analysts Forecast Growth

EHC has been the subject of several analyst reports. Truist Financial boosted their price target on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a report on Thursday, August 14th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. UBS Group boosted their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Bank of America upped their price objective on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Finally, KeyCorp upped their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. One analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $139.86.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.10% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.